Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Biological Psychiatry
|
August 23, 2023
Low-Intensity Focused Ultrasound Targeting the Bilateral Nucleus Accumbens as a Potential Treatment for Substance Use Disorder: A First-in-Human Report
James J Mahoney, Daisy G Y Thompson-Lake, Manish Ranjan, et al.
Journal of Neurosurgery
|
November 5, 2022
Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes
Ali R Rezai, Manish Ranjan, Marc W Haut, et al.
Experimental and Clinical Psychopharmacology
|
May 27, 2021
Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder
James J Mahoney, Marc W Haut, Sally L Hodder, et al.
Device
|
December 15, 2025
Acoustic emissions dose and spatial control of blood-brain barrier opening with focused ultrasound
Graeme F Woodworth, Pavlos Anastasiadis, Ahmad Ozair, et al.
Journal of Neurosurgery
|
June 17, 2023
Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder
Ali R Rezai, James J Mahoney, Manish Ranjan, et al.
World Neurosurgery
|
December 20, 2014
The cognitive and technical skills impact of the Congress of Neurological Surgeons simulation curriculum on neurosurgical trainees at the 2013 Neurological Society of India meeting
Samer G Zammar, Youssef J Hamade, Rami James N Aoun, et al.
Biological Psychiatry
|
March 2, 2015
A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression
Darin D Dougherty, Ali R Rezai, Linda L Carpenter, et al.
Biological Psychiatry
|
October 10, 2008
Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression
Donald A Malone, Darin D Dougherty, Ali R Rezai, et al.
The Lancet. Neurology
|
March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
JCI Insight
|
April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's disease
Martin Niethammer, Chris C Tang, Peter A LeWitt, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Biological Psychiatry
|
August 23, 2023
Low-Intensity Focused Ultrasound Targeting the Bilateral Nucleus Accumbens as a Potential Treatment for Substance Use Disorder: A First-in-Human Report
James J Mahoney, Daisy G Y Thompson-Lake, Manish Ranjan, et al.
Journal of Neurosurgery
|
November 5, 2022
Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes
Ali R Rezai, Manish Ranjan, Marc W Haut, et al.
Experimental and Clinical Psychopharmacology
|
May 27, 2021
Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder
James J Mahoney, Marc W Haut, Sally L Hodder, et al.
Device
|
December 15, 2025
Acoustic emissions dose and spatial control of blood-brain barrier opening with focused ultrasound
Graeme F Woodworth, Pavlos Anastasiadis, Ahmad Ozair, et al.
Journal of Neurosurgery
|
June 17, 2023
Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder
Ali R Rezai, James J Mahoney, Manish Ranjan, et al.
World Neurosurgery
|
December 20, 2014
The cognitive and technical skills impact of the Congress of Neurological Surgeons simulation curriculum on neurosurgical trainees at the 2013 Neurological Society of India meeting
Samer G Zammar, Youssef J Hamade, Rami James N Aoun, et al.
Biological Psychiatry
|
March 2, 2015
A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression
Darin D Dougherty, Ali R Rezai, Linda L Carpenter, et al.
Biological Psychiatry
|
October 10, 2008
Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression
Donald A Malone, Darin D Dougherty, Ali R Rezai, et al.
The Lancet. Neurology
|
March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
JCI Insight
|
April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's disease
Martin Niethammer, Chris C Tang, Peter A LeWitt, et al.
Page
of 14